Essex Bio-Technology (SEHK:1061) Balance Sheet Analysis 2000-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2023	2024	LTM
Total Cash And Short-Term Investments	HK$515.025M	HK$560.739M	HK$642.923M
Net Receivables	HK$637.241M	HK$617.02M	HK$691.904M
Inventory	HK$62.822M	HK$58.938M	HK$64.939M
Prepaid Expenses And Other Current Assets	HK$26.784M	HK$44.669M	HK$42.076M
Other Current Assets	HK$3.406M	HK$1.935M	-
Total Current Assets	HK$1.245B	HK$1.283B	HK$1.442B
Property, Plant And Equipment	HK$416.476M	HK$414.206M	HK$490.649M
Goodwill And Intangible Assets	HK$1.125B	HK$0.939B	HK$1.256B
Long-Term Investments	HK$40.363M	HK$46.973M	HK$29.599M
Deferred Tax Assets	-	-	-
Other Noncurrent Assets	-	HK$299.622M	HK$15.196M
Total Noncurrent Assets	HK$1.582B	HK$1.7B	HK$1.792B
Other Assets	-	-	-
Total Assets	HK$2.828B	HK$2.983B	HK$3.234B

Metric	2023	2024	LTM
Total Payables	HK$99.552M	HK$7.359M	HK$634.34M
Accrued Expenses	HK$390.075M	HK$402.399M	-
Short-Term Debt	HK$235.865M	HK$69.798M	HK$120.164M
Current Portion Of Lease Obligations	HK$1.696M	HK$3.265M	HK$3.302M
Income Taxes Payable	HK$88.971M	HK$90.518M	HK$114.85M
Current Deferred Revenue	-	-	-
Other Current Liabilities	HK$83.557M	HK$226.156M	-
Total Current Liabilities	HK$810.744M	HK$708.978M	HK$757.806M
Long-Term Debt	HK$15.652M	HK$77.124M	HK$132.865M
Capital Lease Obligations	HK$22.101M	HK$21.691M	HK$20.759M
Noncurrent Deferred Revenue	-	-	-
Noncurrent Deferred Tax Liabilities	HK$36.576M	HK$36.372M	HK$34.359M
Other Noncurrent Liabilities	-	-	-
Total Noncurrent Liabilities	HK$93.037M	HK$150.347M	HK$202.138M
Other Liabilities	-	-	-
Total Liabilities	HK$903.781M	HK$859.325M	HK$959.944M

Metric	2023	2024	LTM
Treasury Stock	-	-	-
Preferred Stock	-	-	-
Common Stock	HK$56.759M	HK$56.713M	HK$56.701M
Retained Earnings	HK$1.845B	HK$2.217B	HK$2.255B
Additional Paid-In Capital	HK$73.279M	HK$73.278M	HK$73.278M
Accumulated Other Comprehensive Income	HK$-51.252M	HK$-223.005M	HK$-111.274M
Other Stockholders' Equity	-	-	-
Total Common Stockholders' Equity	HK$1.924B	HK$2.124B	HK$2.274B
Minority Interest	-	-	-
Total Equity	HK$1.924B	HK$2.124B	HK$2.274B
Total Liabilities And Equity	HK$2.828B	HK$2.983B	HK$3.234B

Metric	2023	2024	LTM
Total Investments	HK$45.542M	HK$50.545M	HK$31.989M
Total Debt	HK$294.022M	HK$187.039M	HK$291.245M
Net Debt	HK$-215.823M	HK$-370.128M	HK$-349.288M

Essex Bio-Technology
1061

Balance Sheet

Balance Sheet Composition

Essex Bio-Technology 1061

Balance Sheet

Balance Sheet Composition

Essex Bio-Technology
1061